Usefulness of double vital staining with 1% fluorescein and 1% lissamine green in patients with dry eye syndrome

Cornea

Volumn 30, Issue 9, 2011, Pages 972-976

  Yoon, Kyung Chul ^a   Im, Seong Kyu ^a   Kim, Hwang Gyun ^a   You, In Cheon ^b  

^a Chonnam National University Medical School   (South Korea)

^b Chonbuk National University Medical School   (South Korea)

Author keywords

double vital staining; dry eye syndrome; fluorescein; lissamine green

Indexed keywords

DYE; FLUORESCEIN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONJUNCTIVA; CONTROLLED STUDY; CORNEA; DOUBLE VITAL STAINING; DRY EYE; FEMALE; HUMAN; MALE; MEDICAL PHOTOGRAPHY; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; OCULAR SURFACE DISEASE INDEX; PRIORITY JOURNAL; SJOEGREN SYNDROME; SLIT LAMP; STAINING;

ADULT; AGED; COLORING AGENTS; CONJUNCTIVA; DRY EYE SYNDROMES; FEMALE; FLUORESCEIN; HUMANS; LISSAMINE GREEN DYES; MALE; MIDDLE AGED; STAINING AND LABELING; TEARS;

EID: 80051803008     PISSN: 02773740     EISSN: 15364798     Source Type: Journal    
DOI: 10.1097/ICO.0b013e31820687dd     Document Type: Article

References (28)

1. Pflugfelder SC. Anti-inflammatory therapy of dry eye. Ocul Surf. 2003;1: 31-36.
2. Albertsmeyer AC, Kakkassery V, Spurr-Michaud S, et al. Effect of proinflammatory mediators on membrane-associated mucins expressed by human ocular surface epithelial cells. Exp Eye Res. 2010;90:444-451.
3. Ramamoorthy P, Nichols JJ. Mucins in contact lens wear and dry eye conditions. Optom Vis Sci. 2008;85:631-642.
4. Chen JJ, Rao K, Pflugfelder SC. Corneal epithelial opacity in dysfunctional tear syndrome. Am J Ophthalmol. 2009;148:376-382.
5. Pflugfelder SC, Jones D, Ji Z, et al. Altered cytokine balance in the tear fluid and conjunctiva of patients with Sjögren's syndrome keratoconjunctivitis sicca. Curr Eye Res. 1999;19:201-211.
6. Pflugfelder SC, De Paiva CS, Villarreal AL, et al. Effects of sequential artificial tear and cyclosporine emulsion therapy on conjunctival goblet cell density and transforming growth factor-beta2 production. Cornea. 2008;27:64-69.
7. Korb DR, Herman JP, Finnemore VM, et al. An evaluation of the efficacy of fluorescein, rose bengal, lissamine green, and a new dye mixture for ocular surface staining. Eye Contact Lens. 2008;34:61-64.
8. Vitali C, Bombardieri S, Jonsson R, et al. European study group on classification criteria for Sjögren's syndrome. Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis. 2002;61: 554-558.
9. Lemp MA. Report of the National Eye Institute/Industry Workshop on Clinical Trials in Dry Eyes. CLAO J. 1995;25:695-700.
10. Bron AJ, Evans VE, Smith JA. Grading of corneal and conjunctival staining in the context of other dry eye tests. Cornea. 2003;22:640-650.
11. Schiffman RM, Christianson MD, Jacobsen G, et al. Reliability and validity of the ocular surface disease index. Arch Ophthalmol. 2000;118: 615-621.
12. Dogru M, Katakami C, Inoue M. Tear function and ocular surface changes in noninsulin-dependent diabetes mellitus. Ophthalmology. 2001;108: 586-592.
13. Tsubota K. Tear dynamics and dry eye. Prog Retin Eye Res. 1998;17: 565-596.
14. Kim J. The use of vital dyes in corneal disease Curr Opin Ophthalmol. 2000;11:241-247.
15. Manning FJ, Wehrly SR, Foulks GN. Patient tolerance and ocular surface staining characteristics of lissamine green versus rose bengal. Ophthalmology. 1995;102:1953-1957.
16. Kim J, Foulks GN. Evaluation of the effect of lissamine green and rose bengal on human corneal epithelial cells. Cornea. 1999;18:328-332.
17. Lee SH, Tseng SC. Rose bengal staining and cytologic characteristics associated with lipid tear deficiency. Am J Ophthalmol. 1997;124: 736-750.
18. Bron AJ. The Doyne Lecture: reflections on the tears. Eye (Lond). 1997; 11:583-602.
19. Feenstra RP, Tseng SC. What's actually stained by rose bengal? Arch Ophthalmol. 1992;110:984-993.
20. Feenstra RP, Tseng SC. Comparison of fluorescein and rose Bengal staining. Ophthalmology. 1995;102:1953-1957.
21. Norn MS. Lissamine green. Vital staining of cornea and conjunctiva. Acta Ophthalmol. 1973;51:483-491.
22. Toda I, Tsubota K. Practical double vital staining for ocular surface evaluation. Cornea. 1993;12:366-367.
23. Begley CG, Chalmers RL, Abetz L, et al. The relationship between habitual patient-reported symptoms and clinical signs among patients with dry eye of varying severity. Invest Ophthalmol Vis Sci. 2003;44: 4753-4761.
24. Schein OD, Tielsch JM, Munoz B, et al. Relation between signs and symptoms of dry eye in the elderly. A population-based perspective. Ophthalmology. 1997;104:1395-1401.
25. Hay EM, Thomas E, Pal B, et al. Weak association between subjective symptoms or and objective testing for dry eyes and dry mouth: results from a population based study. Ann Rheum Dis. 1998;57:20-24.
26. Nichols KK, Nichols JJ, Mitchell GL. The lack of association between signs and symptoms in patients with dry eye disease. Cornea. 2004;23: 762-770.
27. Machado LM, Castro RS, Fontes BM. Staining patterns in dry eye syndrome: rose bengal versus lissamine green. Cornea. 2009;28: 732-734.
28. Whitcher JP, Shiboski CH, Shiboski SC, et al. A simplified quantitative method for assessing keratoconjunctivitis sicca from the Sjögren's Syndrome International Registry. Am J Ophthalmol. 2010;149: 405-415.